{"ticker": {"uuid": "916efc5b-4d11-4aba-b347-c3c173b321ef", "symbol": "POXEL", "name": "Poxel S.A.", "exchange": "PAR", "country": "FR", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Poxel Appoints Yves Decadt as CEO, Succeeding Nicolas Trouche", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxOcmpoTHRpckRKLWk5VGI1STFmZWJUVUc3TUE2aHFXU0xaQWlmaTFDdW15ZUhlSFhpRkVCTUZJWV9sSnpqc3BYZGZDWFZiOVJhajgwTjBoaW9aQU1XNnhfREpvLVJWWndkMUprOThEaEwwMTlPcEVLb1FEM3cwZm1zcXNlcTZBTUEwT08wZEtncmtEV2pjb3ByRDV6TFBLZVo1cjA2akRCNUhhbXp4RFRDdVJFV0Z4RVRVUU9Z?oc=5", "source_name": "Id\u00e9al Investisseur", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Poxel Appoints Yves Decadt as Chief Executive Officer to Accelerate Portfolio Development and Strategic Partnerships", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwJBVV95cUxPX2FyWlVJYUpZcDJxNE56X3A5NUh2LWNTeEcyRHF4VjZhRUNGbW5odXVqY3NyZmpRcUNVTkNmMGg2QS1fVVpVUDMwa2xBOWI0MDhFbEJyOVdiYzFTWHRzWUdFMmtfWUVTTXd1X3Z5V3ZFSU84R1U4MS1TT051WjZ5OUdBY0pWNVYzQWFLM3NCS2lJck5YakZ5Z1RUU1hUTk5kRTc3WVVvQlV1SUtNZEM1cVEzc2E3cDdQbGk3OEdaaWNDRHVsdTZ0RWNNcUdZU2o0T25qaTg4aWdIR1FxbURYODVCWG9XeE13VDlKM1l6RHJ1ZktFVFpONXNHX2tFOFZjYTlB?oc=5", "source_name": "Business Wire", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scynexis In Spotlight After Poxel Deal, $40 Million Private Placement \u2013 SCYX Stock Climbs 2% Pre-Market", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxQWWhpTzBqRF9WeWZZYUt1Sy0tVXlUakRtM2ZiTHhNWDhvTVRIaGtlWDQyTnQyalJRYnJ2Z2MxNWM0OFFiVExodU9XMjRHdUZyRS1hSDQwWE01ckhrUDFiWG9zaG5XazdrSGs5R3djWHVnaGJ3bG9EV1NhZkVucndjZ3BGMDlUeklrLVJkdmdGMWkzSzdjM0lMcGgybjI2NU5YR0NrellZa3dKT0U?oc=5", "source_name": "Stocktwits", "published_at": "2026-03-31T07:00:00+00:00", "published_display": "31 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Poxel Announces the Implementation of an Equity Line With IRIS Capital as Part of the Execution of the Recovery Plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7AFBVV95cUxQSzdGRXlxN0VwY2JscnREbTRqendxQ3E3SEIySHJhTVpEWlNlcF9XLXI4eFc4TjhtLXVGLTU0ZnVCcC0ydXhHSkh2dmk4QzlvRXJsQnFPT1NyTlZybWxZYUc4aDBQSkVYcnoxRVFXeTBpajF1Q09FRU5TM2drLTU0Tno4bFlQN2EzbXpwMThoemNRS2hHdktteFVTNnhTV3JIdXR2LTNZaFZRcVE4ZGhLbkR3bEw2VWUzWlpyemFyLWJrOEM3ZllIejVjV2VmQ2cwNHA2ZWwwejdkbDYwdlFYQXVhNDhHYk5SQjROSQ?oc=5", "source_name": "BioSpace", "published_at": "2026-02-03T08:00:00+00:00", "published_display": "03 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Poxel takes first step in recovery plan with \u20ac5 million equity line", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxQV1ctUnBSeHlLUmhXLVljR29NZGwzTlNiWEFyeWZWZktuQi05WDZNRFpGTmlJc01NSWJRWU1wM2RiVlhXVmZweWtGRk9MVXNGbXBuTGdPNUE4NWF3Uk1UbmpWOUE2eUZxeDhTU0RQbjBGTzNDYUhucjFWVVBJamJTeFVXcTN4bmdHS0VZSHltSQ?oc=5", "source_name": "European Biotechnology Magazine", "published_at": "2026-02-03T08:00:00+00:00", "published_display": "03 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Poxel: Availability of a Second Document Addressing Questions Received From Shareholders", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxPdHdJNHlUZm5BQjN2S0F4UVd6Z2pfS19yMUFHVHkxWEhEWUYtZWFqdjZxZEI4RjdidHE1cXozUmZRd3Y0VVBXb19sTVJ0Z2NWeWR4VDFoVHpqWDl6dXZfSFBzRW8wMmhNcm1aWHlsRGp5X0RJN1daWVBzckV6ejRsTVZqdWo0TVR0Uk9UanllVVhLaFdEV3haQzlIRU91VTJudnhhb1lIaFJJUDFjaUdvRnhFYUc4X3VlRzY1bndlcnNGVkJ4a3VELW5yb05xdUdTUjVTcktFNGg4XzJq?oc=5", "source_name": "Business Wire", "published_at": "2025-11-05T08:00:00+00:00", "published_display": "05 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "POXEL SA - New Clinical and Scientific Data on TWYMEEG to be presented at the 68th Annual Meeting of the Japan Diabetes Society", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAJBVV95cUxNdzhwR3BKYjFZbEZCNGRpdjlmbWlic0oxNU05ZXJZU2dxNkZlV0dCazZqR28zWUh5Z3lvcEs3UzRPUmN5M044U2N2UWlxZTFBY256TUY5YVRoRUF2SW1LdkpCNWFWWlRjWFFaREZTbHo4eWkwQ3hISHNXaWpQNWlUWGpQY0hzcUhPbDhOSFQ4enlBdDJiQ2dmajk3V29KUWZvNmFHSHN5MC1pNWYzQzN2YXloVjJpQVZVZHlicTZyY2NEQ1JqaXVFZUxZNFdORWhlQnhZejlfWkh3TFZPcGU4ZlkyelBlS2p6VFRPZWJ5dnRKRUJVNkJmSDF5ckdjQ2Ju?oc=5", "source_name": "marketscreener.com", "published_at": "2025-05-29T07:00:00+00:00", "published_display": "29 May 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Poxel Appoints Yves Decadt as CEO, Succeeding Nicolas Trouche", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxOcmpoTHRpckRKLWk5VGI1STFmZWJUVUc3TUE2aHFXU0xaQWlmaTFDdW15ZUhlSFhpRkVCTUZJWV9sSnpqc3BYZGZDWFZiOVJhajgwTjBoaW9aQU1XNnhfREpvLVJWWndkMUprOThEaEwwMTlPcEVLb1FEM3cwZm1zcXNlcTZBTUEwT08wZEtncmtEV2pjb3ByRDV6TFBLZVo1cjA2akRCNUhhbXp4RFRDdVJFV0Z4RVRVUU9Z?oc=5", "source_name": "Id\u00e9al Investisseur", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Poxel Appoints Yves Decadt as Chief Executive Officer to Accelerate Portfolio Development and Strategic Partnerships", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwJBVV95cUxPX2FyWlVJYUpZcDJxNE56X3A5NUh2LWNTeEcyRHF4VjZhRUNGbW5odXVqY3NyZmpRcUNVTkNmMGg2QS1fVVpVUDMwa2xBOWI0MDhFbEJyOVdiYzFTWHRzWUdFMmtfWUVTTXd1X3Z5V3ZFSU84R1U4MS1TT051WjZ5OUdBY0pWNVYzQWFLM3NCS2lJck5YakZ5Z1RUU1hUTk5kRTc3WVVvQlV1SUtNZEM1cVEzc2E3cDdQbGk3OEdaaWNDRHVsdTZ0RWNNcUdZU2o0T25qaTg4aWdIR1FxbURYODVCWG9XeE13VDlKM1l6RHJ1ZktFVFpONXNHX2tFOFZjYTlB?oc=5", "source_name": "Business Wire", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scynexis In Spotlight After Poxel Deal, $40 Million Private Placement \u2013 SCYX Stock Climbs 2% Pre-Market", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxQWWhpTzBqRF9WeWZZYUt1Sy0tVXlUakRtM2ZiTHhNWDhvTVRIaGtlWDQyTnQyalJRYnJ2Z2MxNWM0OFFiVExodU9XMjRHdUZyRS1hSDQwWE01ckhrUDFiWG9zaG5XazdrSGs5R3djWHVnaGJ3bG9EV1NhZkVucndjZ3BGMDlUeklrLVJkdmdGMWkzSzdjM0lMcGgybjI2NU5YR0NrellZa3dKT0U?oc=5", "source_name": "Stocktwits", "published_at": "2026-03-31T07:00:00+00:00", "published_display": "31 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Poxel Announces the Implementation of an Equity Line With IRIS Capital as Part of the Execution of the Recovery Plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7AFBVV95cUxQSzdGRXlxN0VwY2JscnREbTRqendxQ3E3SEIySHJhTVpEWlNlcF9XLXI4eFc4TjhtLXVGLTU0ZnVCcC0ydXhHSkh2dmk4QzlvRXJsQnFPT1NyTlZybWxZYUc4aDBQSkVYcnoxRVFXeTBpajF1Q09FRU5TM2drLTU0Tno4bFlQN2EzbXpwMThoemNRS2hHdktteFVTNnhTV3JIdXR2LTNZaFZRcVE4ZGhLbkR3bEw2VWUzWlpyemFyLWJrOEM3ZllIejVjV2VmQ2cwNHA2ZWwwejdkbDYwdlFYQXVhNDhHYk5SQjROSQ?oc=5", "source_name": "BioSpace", "published_at": "2026-02-03T08:00:00+00:00", "published_display": "03 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Poxel takes first step in recovery plan with \u20ac5 million equity line", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxQV1ctUnBSeHlLUmhXLVljR29NZGwzTlNiWEFyeWZWZktuQi05WDZNRFpGTmlJc01NSWJRWU1wM2RiVlhXVmZweWtGRk9MVXNGbXBuTGdPNUE4NWF3Uk1UbmpWOUE2eUZxeDhTU0RQbjBGTzNDYUhucjFWVVBJamJTeFVXcTN4bmdHS0VZSHltSQ?oc=5", "source_name": "European Biotechnology Magazine", "published_at": "2026-02-03T08:00:00+00:00", "published_display": "03 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Poxel: Availability of a Second Document Addressing Questions Received From Shareholders", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxPdHdJNHlUZm5BQjN2S0F4UVd6Z2pfS19yMUFHVHkxWEhEWUYtZWFqdjZxZEI4RjdidHE1cXozUmZRd3Y0VVBXb19sTVJ0Z2NWeWR4VDFoVHpqWDl6dXZfSFBzRW8wMmhNcm1aWHlsRGp5X0RJN1daWVBzckV6ejRsTVZqdWo0TVR0Uk9UanllVVhLaFdEV3haQzlIRU91VTJudnhhb1lIaFJJUDFjaUdvRnhFYUc4X3VlRzY1bndlcnNGVkJ4a3VELW5yb05xdUdTUjVTcktFNGg4XzJq?oc=5", "source_name": "Business Wire", "published_at": "2025-11-05T08:00:00+00:00", "published_display": "05 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "POXEL SA - New Clinical and Scientific Data on TWYMEEG to be presented at the 68th Annual Meeting of the Japan Diabetes Society", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAJBVV95cUxNdzhwR3BKYjFZbEZCNGRpdjlmbWlic0oxNU05ZXJZU2dxNkZlV0dCazZqR28zWUh5Z3lvcEs3UzRPUmN5M044U2N2UWlxZTFBY256TUY5YVRoRUF2SW1LdkpCNWFWWlRjWFFaREZTbHo4eWkwQ3hISHNXaWpQNWlUWGpQY0hzcUhPbDhOSFQ4enlBdDJiQ2dmajk3V29KUWZvNmFHSHN5MC1pNWYzQzN2YXloVjJpQVZVZHlicTZyY2NEQ1JqaXVFZUxZNFdORWhlQnhZejlfWkh3TFZPcGU4ZlkyelBlS2p6VFRPZWJ5dnRKRUJVNkJmSDF5ckdjQ2Ju?oc=5", "source_name": "marketscreener.com", "published_at": "2025-05-29T07:00:00+00:00", "published_display": "29 May 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 77, "total_relevant": 7, "sentiment_summary": {"positive": 2, "negative": 0, "neutral": 5, "score": 55, "total": 7, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 82, "events": [{"event": "general", "label": "Market update", "weight": 3.3, "count": 6}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 2, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 0.2, "latest_week": "2026-07-10", "one_week_move": 0.2, "four_week_move": -2.2, "twelve_week_move": -26.5, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.054508, "market_dynamics_buy_signal": false, "relative_strength": -33.190289, "fair_value_gap": -48.4, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 32.619, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.2% over one week, -2.2% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 55, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Business Wire", "count": 2}, {"label": "Id\u00e9al Investisseur", "count": 1}, {"label": "Stocktwits", "count": 1}, {"label": "BioSpace", "count": 1}, {"label": "European Biotechnology Magazine", "count": 1}, {"label": "marketscreener.com", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 7}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 6}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "55/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "82/100 classification confidence."}, {"label": "Company focus", "value": "7", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+0.2% over one week, -2.2% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Poxel Appoints Yves Decadt as CEO, Succeeding Nicolas Trouche"}], "updated_at": "2026-07-17T23:55:42.125929+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}